http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111187773-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
| filingDate | 2020-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111187773-B |
| titleOfInvention | Long non-coding RNA gene marker for detecting liver cancer and application thereof |
| abstract | A long non-coding RNA gene marker for detecting liver cancer and application thereof are provided, wherein the long non-coding RNA is LINC 01141. According to the invention, the expression of LINC01141 in a liver cancer patient is obviously up-regulated through fluorescent quantitative PCR detection, which shows that LINC01141 can be used as a gene marker of liver cancer and is used for diagnosis and treatment of the liver cancer. The invention has the beneficial effects that the early diagnosis of the liver cancer can be realized by detecting the expression level of LINC01141 in the liver cancer patient, so that the survival rate of the liver cancer patient is improved. Secondly, the invention provides an application of LINC01141 siRNA in preparing a liver cancer medicine composition, and the medicine composition can be used as a new treatment medicine for treating liver cancer patients, and has important clinical value and application prospect. |
| priorityDate | 2020-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 197.